Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay-Results From the SAFIA Phase III Trial.
AlSaleh K, Al Zahwahry H, Bounedjar A, Oukkal M, Saadeddine A, Mahfouf H, Bouzid K, Bensalem A, Filali T, Abdel-Razeq H, Larbaoui B, Kandil A, Abulkhair O, Al Foheidi M, Errihani H, Ghosn M, Abdel-Aziz N, Arafah M, Boussen H, Dabouz F, Rasool H, Bahadoor M, Ayari J, Kullab S, Nabholtz JM. AlSaleh K, et al. Among authors: ghosn m. JCO Glob Oncol. 2021 Jun;7:811-819. doi: 10.1200/GO.20.00575. JCO Glob Oncol. 2021. PMID: 34086481 Free PMC article. Clinical Trial.
OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma.
Ghosn M, Eid R, Hamada E, Abdel Azim H, Zekri J, Al-Mansour M, Jaloudi M, Nasr F, Errihani H, Bounedjar A, Mezlini A, Boussen H, Kattan J, El Karak F, Farhat F; Africa Middle East Cancer Intergroup. Ghosn M, et al. J Glob Oncol. 2019 Oct;5:1-10. doi: 10.1200/JGO.18.00238. J Glob Oncol. 2019. PMID: 31657977 Free PMC article.
The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA region.
Elghazaly H, Aref AT, Anderson BO, Arun B, Yip CH, Abdelaziz H, Ghosn M, Al-Foheidi M, Cardenosa G, Leung JWT, Gado N, Balch CM, Sabry M, Ezz Elarab L, Giuliano AE, El-Zawahry HM, Abdel Karim K, Nasr A, Maki H, Chung H, Saadeddin A, Abdelwahab MM, Al Tahan FM, Chalabi N, Frolova M, Kamal RM, Shehata MA, Bahie Eldin N, Elghazawy H. Elghazaly H, et al. Among authors: ghosn m. Int J Cancer. 2021 Aug 1;149(3):505-513. doi: 10.1002/ijc.33506. Epub 2021 Feb 21. Int J Cancer. 2021. PMID: 33559295 Free article.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Triple-negative breast cancer in Lebanon: a case series.
Ghosn M, Hajj C, Kattan J, Farhat F, El Karak F, Nasr F, Abadjian G, Chahine G. Ghosn M, et al. Oncologist. 2011;16(11):1552-6. doi: 10.1634/theoncologist.2011-0088. Epub 2011 Oct 21. Oncologist. 2011. PMID: 22020211 Free PMC article.
Triple negative breast cancer: are we scoring a home run?
El Rassy E, Ibrahim N, Ghosn M. El Rassy E, et al. Among authors: ghosn m. Future Oncol. 2018 Apr;14(9):793-796. doi: 10.2217/fon-2017-0656. Epub 2018 Mar 12. Future Oncol. 2018. PMID: 29527949 No abstract available.
219 results